Overview
Chinmoy Sarkar practices in Hong Kong, China. Sarkar and is rated as an Elite expert by MediFind in the treatment of CLN1 Disease. Their top areas of expertise are Batten Disease, CLN3 Disease, CLN1 Disease, and CLN5 Disease.
Their clinical research consists of co-authoring 65 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of CLN1 Disease.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Batten DiseaseSarkar isElite. Learn about Batten Disease.
- CLN1 DiseaseSarkar isElite. Learn about CLN1 Disease.
- CLN3 DiseaseSarkar isElite. Learn about CLN3 Disease.
- CLN4 DiseaseSarkar isElite. Learn about CLN4 Disease.
- CLN5 DiseaseSarkar isElite. Learn about CLN5 Disease.
- Distinguished
- CLN2 DiseaseSarkar isDistinguished. Learn about CLN2 Disease.
- Advanced
- Traumatic Brain InjurySarkar isAdvanced. Learn about Traumatic Brain Injury.
- Experienced
- HypertensionSarkar isExperienced. Learn about Hypertension.
- N-Acetyl-Alpha-D-Galactosaminidase Deficiency Type 3
- ObesitySarkar isExperienced. Learn about Obesity.